![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cipher Closes Transaction With IMAGIN Diagnostics
Cipher Closes Transaction With IMAGIN Diagnostics
May 4, 2005
Cipher Holding announced that it has successfully acquired a secured convertible debt position in Positron. Positron is a U.S.-based, publicly traded manufacturer of positron emission tomography (PET) scanners from IMAGIN Diagnostics Centres, a Canadian corporation. As a result of this acquisition, Cipher Holding has issued 30 million common shares from its treasury.
PrimeZone (http://www.primezone.com/newsroom/?d=77569)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct